Bespak to Cut Jobs as Exubera Prospect Falls Short

Bespak, one of the two contract manufacturers of Pfizer’s inhaled insulin Exubera, has announced it will cut a “significant” number of jobs as sales of the once-touted blockbuster are falling short of expectations.
Outsourcing-Pharma.com